RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How To Streamline The Complexity Of Clinical Trials
Streamlining intricate end-to-end processes ensures that data moves with speed and security, converting the current landscape of logistical bottlenecks into a transparent, high-efficiency engine.
-
Is Your Clinical Supply Chain Fully Optimized?
Streamlined supply chain operations alleviate staff workload and significantly reduce IP waste. With the right partners, you can create a fully optimized, cost-effective supply chain strategy.
-
Endpoint Reliability And eCOA Solutions Facilitate CNS Trial Success
A Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.
-
How eCOA Improves Patient Experience
Explore how to ensure that clinical trials are truly patient-centered, and why it is critical to do so.
-
Exploring The Potential Of Non-Consumer Smartphones In Clinical Trials
We selected and evaluated a non-consumer device, to explore its potential as a reliable tool for home-based ePRO measure administration. Here’s what we learned from this usability testing.
-
The Significance Of Quality Data In Meeting FDA Regulatory Scrutiny
Data Science expert Rod McGlashing explains how scrutiny from the FDA spurs regulatory compliance, resulting in better data quality and the creation of optimal applications for intellectual property.
-
The FDA's Remote Regulatory Assessments: The Future Of Inspections
Remote Regulatory Assessments (RRAs) provide distinct advantages over traditional inspections, such as increased efficiency, reduced travel costs, and enhanced global oversight capabilities.
-
Achieving Faster, Simpler Validation Through Crowdsource UAT
An approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.
-
Quality By Design: How eCOA Improves Data Oversight And Quality
Unearth the innovative ways electronic clinical outcome assessments (eCOA) are improving data accuracy, reducing errors, and ensuring robust oversight in clinical trials.
-
AI In Clinical Trials: Key Insights From Industry Experts
Find out what experts from the FDA are saying about AI’s ability to demonstrably impact three critical success metrics in clinical trials.
RECENT NEWSLETTERS
- 06.06.26 -- Best Of May: AI Risk, CRO Strategy, And Trial Cost Control
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials